skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
Fas Receptor Agonist APO010 (Code C67041)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Fas Receptor Agonist APO010

Definition: A recombinant, soluble, hexameric fusion protein consisting of three human Fas ligand (FasL) extracellular domains fused to the dimer-forming collagen domain of human adiponectin with potential pro-apoptotic and antineoplastic activities. Assembled into a soluble hexameric structure mimicking the ligand clustering of endogenous active FasL, Fas receptor agonist APO010 activates the Fas receptor, resulting in caspase-dependent apoptosis in susceptible tumor cell populations. FasL is a transmembrane protein of the tumor necrosis factor (TNF) superfamily and a pro-apoptotic ligand for the death receptor Fas.

Label: Fas Receptor Agonist APO010

NCI Thesaurus Code: C67041 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1879517  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Fas Receptor Agonist APO010

External Source Codes: 
PDQ Closed Trial Search ID 539307
PDQ Open Trial Search ID 539307 (check for NCI PDQ open clinical trial info)
UMLS CUI C1879517

Other Properties:
     Name Value (qualifiers indented underneath)
code C67041
Legacy_Concept_Name APO010
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom